Home › Free Stock Grades › KMTS
Kestra Medical Technologies, Ltd. (KMTS) Stock Grade
KMTS · Healthcare
C
Market Cap
$1.6B
P/E Ratio
—
Revenue Growth (YoY)
+59.0%
Net Margin
-138.4%
Return on Equity
—
Dividend Yield
0.0%
About Kestra Medical Technologies, Ltd.'s fundamentals
Kestra Medical Technologies is a $1.6 billion medical devices company experiencing robust revenue growth of 59.0% year-over-year, indicating strong market demand for its products. However, the company is currently unprofitable, with a net margin of -138.4%, meaning it is losing $1.38 for every dollar of revenue generated. The company does not pay a dividend to shareholders. These metrics suggest Kestra is in a growth phase prioritizing market expansion and product development over profitability.